Breakthrough experimental therapy to treat colon cancer, chronic inflammatory bowel disease
A groundbreaking experimental therapy has been discovered that has the ability to suppress the development of ulcerative colitis (UC), a disease which causes inflammation in the digestive tract and colon cancer. The treatment utilizes a chemical inhibitor able to block an RNA molecule (microRNA-214) involved in the transmission of genetic information.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cancer | Cancer & Oncology | Chemistry | Colon Cancer | Colorectal Cancer | Genetics | Inflammatory Bowel Disease | Science | Ulcerative Colitis